Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases

Gastroenterology

Volumn 136, Issue 2, 2009, Pages 376-386

  Everhart, James E ^a   Ruhl, Constance E ^a  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; MESALAZINE; OMEPRAZOLE; PANTOPRAZOLE; PEGINTERFERON ALPHA2A; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; RIBAVIRIN; TEGASEROD;

ABDOMINAL WALL HERNIA; AMBULATORY CARE; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONSTIPATION; COST BENEFIT ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; DIVERTICULOSIS; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CANCER; ETHNIC AND RACIAL GROUPS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEMORRHOID; HEPATITIS C; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INTESTINE INFECTION; IRRITABLE COLON; MEDICAL CARE; MEDICAL FEE; MORTALITY; NATIONAL HEALTH ORGANIZATION; OUTPATIENT DEPARTMENT; PANCREATITIS; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL TIME; UNITED STATES; VIRUS HEPATITIS;

EID: 58649100685     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.12.015     Document Type: Article

References (11)

1. Burden of digestive diseases in the United States (2008), US Government Printing Office, Washington, DC NIH publication no. 09-6443, pp 1-182.
2. Everhart J.E. Overview. In: Everhart J.E. (Ed). Digestive diseases in the United States: epidemiology and impact (1994), US Government Printing Office, Washington, DC 1-50 NIH publication no. 94-1447
3. Hodgson T.A. The state of the art of cost-of-illness estimates. Adv Health Econ Health Serv Res 4 (1983) 129-164
4. Brown D.M., and Everhart J.E. Cost of digestive diseases in the United States. In: Everhart J.E. (Ed). Digestive diseases in the United States: epidemiology and impact (1994), US Government Printing Office, Washington, DC 55-82 NIH publication no. 94-1447
5. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
6. Smith C., Cowan C., Heffler S., et al. National health spending in 2004: recent slowdown led by prescription drug spending. Health Aff (Millwood) 25 (2006) 186-196
7. Seeff L.C., Richards T.B., Shapiro J.A., et al. How many endoscopies are performed for colorectal cancer screening?. Results from CDC's survey of endoscopic capacity. Gastroenterology 127 (2004) 1670-1677
8. Sonnenberg A., Amorosi S.L., Lacey M.J., et al. Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. Gastrointest Endosc 67 (2008) 489-496
9. National Cancer Institute. SEER cancer statistics review 1975-200. http://seer.cancer.gov/csr/1975_2005/results_merged/topic_med_age.pdf
10. Sonnenberg A. Esophageal diseases. In: Everhart J.E. (Ed). Digestive diseases in the United States: epidemiology and impact (2004), US Government Printing Office, Washington, DC 299-355 NIH publication no. 94-1447
11. Sonnenberg A. Peptic ulcer. In: Everhart J.E. (Ed). Digestive diseases in the United States: epidemiology and impact (1994), US Government Printing Office, Washington, DC 357-408 NIH publication no. 94-1447